| Name | Title | Contact Details |
|---|---|---|
Shalom Shushan |
Chief Technology Officer | Profile |
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.
A few individuals with decades of experience in the U.S. orthopedic industry,came together in 2015 because they saw the need for a first-class company that was Agile,creative and innovative in a global market subject to advancing technologies and changing policies.They had seen the successes of the large companies, but they had witnessed compromises that had to be made.
Conceptus, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Concorde Medical Group PLLC is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Care System Consultants, Inc is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.